Variables | Group (%) | P-value | ||
---|---|---|---|---|
New case | Previously treated case | |||
Demographic | ||||
Gender | Female | 36 (16.1) | 70 (15.7) | 0.909 |
Male | 188 (83.9) | 375 (84.3) | ||
Age | 20-34 | 47 (21.0) | 122 (27.4) | 0.158 |
35-49 | 95 (42.4) | 183 (41.1) | ||
50- | 82 (36.6) | 140 (31.5) | ||
Health condition | ||||
BMI (n = 626) | <18.5 | 108 (50.2) | 204 (49.6) | 0.887 |
18.5- | 107 (49.8) | 207 (50.4) | ||
Diabetes | No | 180 (80.4) | 340 (76.4) | 0.246 |
Yes | 44 (19.6) | 105 (23.6) | ||
Individual behavior | ||||
Alcohol, within 6 months | Less than once a week | 102 (45.5) | 245 (55.1) | 0.062 |
Several times a week | 39 (17.4) | 68 (15.3) | ||
At least once a day | 83 (37.1) | 132 (29.7) | ||
Smoking, within 6 months | Never smoked | 56 (25.0) | 125 (28.1) | <0.001 |
< 1 pack/day | 30 (12.39) | 125 (28.1) | ||
1 pack/day | 78 (34.8) | 121 (27.2) | ||
> 1 pack/day | 60 (26.8) | 74 (16.6) | ||
Socioeconomic | ||||
Residential area | Small city and town | 135 (60.3) | 245 (55.1) | 0.199 |
Large city | 89 (39.7) | 200 (44.9) | ||
Education | High school, above | 120 (53.6) | 251 (56.4) | 0.487 |
Middle school, below and refusal | 104 (46.4) | 194 (43.6) | ||
Occupation | Health care, professional, office work | 16 (7.1) | 55 (12.4) | 0.117 |
Service sector and laborer in construction or factory | 128 (57.1) | 242 (54.4) | ||
Unemployment and others | 80 (35.7) | 148 (33.3) | ||
Housing status (n = 668) | Private | 201 (89.7) | 415 (93.5) | 0.089 |
Other | 23 (10.3) | 29 (6.5) | ||
Tuberculosis-related clinical | ||||
Chest X ray | ||||
Grade | Minimal | 10 (4.5) | 9 (2.0) | 0.020 |
Moderately advanced | 111 (49.6) | 187 (42.0) | ||
Far advanced | 103 (46.0) | 249 (56.0) | ||
Cavity | Yes | 138 (61.6) | 281 (63.1) | <0.001 |
No | 68 (30.4) | 78 (17.5) | ||
Not clear | 18 (8.0) | 86 (19.3) | ||
Bilateral | Unilateral | 57 (25.4) | 56 (12.6) | <0.001 |
Bilateral | 167 (74.6) | 389 (87.4) | ||
Nodular lesion | Yes | 199 (88.8) | 417 (93.7) | 0.038* |
No | 22 (9.8) | 27 (6.1) | ||
Not clear | 3 (1.3) | 1 (0.2) | ||
Treatment History | ||||
Number of previous treatment episode (n = 444) | 1 | - | 151 (33.9) | - |
2 | - | 106 (23.8) | ||
3 | - | 63 (14.2) | ||
4 or more | - | 125 (28.1) | ||
Cumulative duration of previous treatment (days, n = 444) | Median (IQR) | - | 304 (61-761) | - |
History of failure (n = 445) | No | - | 249 (56.0) | - |
Yes | - | 196 (44.0) | ||
History of treatment interruption (n = 445) | No | - | 207 (46.5) | - |
Yes | - | 238 (53.5) | ||
Drug Susceptibility pattern (n = 581) | DS | 146 (75.0) | 92 (26.5) | <0.001* |
Mono/Poly-R | 29 (14.8) | 44 (11.4) | ||
Rif, mono-R | 4 (2.0) | 16 (4.2) | ||
MDR | 16 (8.2) | 223 (57.9) | ||
AFB smear score at baseline | ||||
- | 1 (0.5) | 4 (0.9) | 0.689* | |
Scant | 51 (22.8) | 85 (19.1) | ||
1+ | 121 (54.0) | 247 (55.5) | ||
≥2+ | 51 (22.8) | 109 (24.5) |